RNASKIP Trademark

Trademark Overview

On Friday, March 29, 2019, a trademark application was filed for RNASKIP with the United States Patent and Trademark Office. The USPTO has given the RNASKIP trademark a serial number of 88363697. The federal status of this trademark filing is REGISTERED as of Tuesday, November 29, 2022. This trademark is owned by Shape Therapeutics, Inc.. The RNASKIP trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

product development in the field of identifying genetic therapy; research and development of technology in the field of genetic therapy; scientific research for medical purposes in the field of genetic therapy
rnaskip

General Information

Serial Number88363697
Word MarkRNASKIP
Filing DateFriday, March 29, 2019
Status700 - REGISTERED
Status DateTuesday, November 29, 2022
Registration Number6913357
Registration DateTuesday, November 29, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 16, 2019

Trademark Statements

Pseudo MarkRIBONUCLEIC ACID SKIP
Pseudo MarkRNA SKIP
Goods and Servicesproduct development in the field of identifying genetic therapy; research and development of technology in the field of genetic therapy; scientific research for medical purposes in the field of genetic therapy

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, April 17, 2019
Primary Code042
First Use Anywhere DateTuesday, May 17, 2022
First Use In Commerce DateTuesday, May 17, 2022

Trademark Owner History

Party NameShape Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98109
Party NameShape Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98109
Party NameShape Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92126

Trademark Events

Event DateEvent Description
Thursday, July 6, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 6, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 6, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 6, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, July 6, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 29, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, November 29, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, October 25, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, October 24, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, September 13, 2022STATEMENT OF USE PROCESSING COMPLETE
Friday, September 9, 2022USE AMENDMENT FILED
Friday, September 9, 2022TEAS STATEMENT OF USE RECEIVED
Thursday, March 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 2, 2022SOU EXTENSION 5 GRANTED
Wednesday, February 23, 2022SOU EXTENSION 5 FILED
Wednesday, February 23, 2022TEAS EXTENSION RECEIVED
Tuesday, September 14, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, September 11, 2021SOU EXTENSION 4 GRANTED
Friday, September 3, 2021SOU EXTENSION 4 FILED
Saturday, September 11, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, September 3, 2021TEAS EXTENSION RECEIVED
Thursday, August 19, 2021TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, June 2, 2021ASSIGNED TO EXAMINER
Friday, February 26, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 24, 2021SOU EXTENSION 3 GRANTED
Wednesday, February 24, 2021SOU EXTENSION 3 FILED
Wednesday, February 24, 2021TEAS EXTENSION RECEIVED
Friday, July 31, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 29, 2020SOU EXTENSION 2 GRANTED
Wednesday, July 29, 2020SOU EXTENSION 2 FILED
Wednesday, July 29, 2020TEAS EXTENSION RECEIVED
Thursday, February 13, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 11, 2020SOU EXTENSION 1 GRANTED
Tuesday, February 11, 2020SOU EXTENSION 1 FILED
Tuesday, February 11, 2020TEAS EXTENSION RECEIVED
Tuesday, September 10, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 16, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 16, 2019PUBLISHED FOR OPPOSITION
Wednesday, June 26, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 12, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 10, 2019ASSIGNED TO EXAMINER
Wednesday, April 17, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 2, 2019NEW APPLICATION ENTERED

Related Keywords

rnaskip genetic field therapy development research medical purposes scientific technology identifying